Provident Financial (PROV) director exercises options for 7,000 shares
Rhea-AI Filing Summary
Provident Financial Holdings director Matthew Webb exercised stock options for 7,000 shares of common stock at $12.09 per share on July 30, 2026, increasing his direct holdings to 8,000 shares. He continues to hold 17,000 stock options from 2023 and 2024 grants under the Provident 2022 Equity Incentive Plan with vesting dates in 2026, 2027 and 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 7,000 shares
Net Buy
2 txns
Insider
Webb Matthew
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock F2 | 7,000 | $0.00 | $0.00 |
| Exercise | Common Stock, PAR Value $0.01 F1 | 7,000 | $12.09 | $85K |
Holdings After Transaction:
Option to Purchase Common Stock — 17,000 shares (Direct);
Common Stock, PAR Value $0.01 — 8,000 shares (Direct)
Footnotes (2)
- F1. Reflects the exercise of stock options under the Provident 2022 Equity Incentive Plan granted on December 14, 2023, and vested on December 14, 2025.
- F2. Includes 7,000 remaining stock options granted on December 14, 2023 under the Provident 2022 Equity Incentive Plan, which vest on December 14, 2027. Also includes the 10,000 stock options granted on May 23, 2024 under the Provident 2022 Equity Incentive Plan, 50% of which vested on May 23, 2026 and 50% of which will vest on May 23, 2028.
Key Figures
Options Exercised: 7,000 shares
Exercise Price: $12.09 per share
Common Shares After Transaction: 8,000 shares
+3 more
6 metrics
Options Exercised
7,000 shares
Common stock acquired on July 30, 2026 through stock option exercise
Exercise Price
$12.09 per share
Exercise or conversion price for 7,000 stock options into common shares
Common Shares After Transaction
8,000 shares
Direct Provident Financial common stock holdings following the reported transactions
Remaining Stock Options
17,000 options
Unexercised options held after the July 30, 2026 option exercise
2023 Grant Vesting Date
December 14, 2027
Remaining 7,000 options from December 14, 2023 grant vest on this date
2024 Grant Vesting Schedule
May 23, 2026 and May 23, 2028
10,000 options; 50% vested in 2026 and 50% vest in 2028
Key Terms
Option to Purchase Common Stock, Provident 2022 Equity Incentive Plan, vested
3 terms
Option to Purchase Common Stock financial
"Listed as the security title "Option to Purchase Common Stock" for the derivative transaction"
Provident 2022 Equity Incentive Plan financial
"Reflects the exercise of stock options under the Provident 2022 Equity Incentive Plan granted on December 14, 2023"
vested financial
"50% of which vested on May 23, 2026 and 50% of which will vest on May 23, 2028"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Matthew Webb report for Provident Financial (PROV)?
Matthew Webb exercised stock options for 7,000 shares of Provident Financial common stock at $12.09 per share on July 30, 2026. These shares came from options granted under the Provident 2022 Equity Incentive Plan that vested on December 14, 2025.
What Provident 2022 Equity Incentive Plan options does Matthew Webb still hold at PROV?
Matthew Webb retains 17,000 stock options: 7,000 from a December 14, 2023 grant vesting December 14, 2027, and 10,000 from a May 23, 2024 grant, half of which vested May 23, 2026 and half vest May 23, 2028.
What was the exercise price of Matthew Webb’s Provident Financial (PROV) stock options?
The exercised stock options had an exercise price of $12.09 per share. Webb converted 7,000 options into common stock at this price, increasing his direct ownership and reducing his outstanding options position accordingly.
Were Matthew Webb’s Provident Financial (PROV) transactions under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox was not marked as affirmative for these transactions. That means the reported option exercise and resulting share acquisition were not affirmed as being executed under a pre-arranged Rule 10b5-1 trading plan.
What future vesting dates apply to Matthew Webb’s remaining PROV stock options?
His remaining options include 7,000 from a December 14, 2023 grant that vest on December 14, 2027, and 10,000 from a May 23, 2024 grant, with 50% vesting on May 23, 2028 after half already vested on May 23, 2026.